|
Injection
of artificial blood clots close to nonpalpable breast abnormalities
identified by an MRI may enable accurate detection and surgical
removal of the tissue, according to researchers at the University
of Arkansas for Medical Sciences in Little Rock.
Abnormal tissue
is sometimes missed with needle localization breast biopsies because
of slippage or wires placed under MRI guidance, according to the
study published in Annals of Surgery.
Hematomas
are easily identified by ultrasound so by injecting a patient's
own clotted blood at the abnormal sites, biopsies can then be
performed under ultrasound guidance, according to the researchers.
The procedure takes about an hour.
Researchers
said they were able to create hematomas in 19 of 20 patients and
an ultrasound or direct visualization confirmed the removal of
the hematomas in all 19. Eight of the biopsies in the study group
proved to be malignant.
"This technique
can be used not only to localize a MRI-detected lesion, but also
to outline the targeted lesion for complete excision and to obtain
margins," said Dr. Suzanne Klimberg, co-author of the study.
The procedure
is potentially more comfortable for the patient because no wire
or needle is left in the breast. It is technically faster and
easier because ultrasound is used to visualize directly the location
of the hematoma at surgery and to confirm lesion removal in the
operating room by specimen ultrasound, according to the researchers.
Other
sources: Annals of Surgery, Reuters
|